Sign in to view content

Do scheduling issues impact commonly needed testing for patients with moderate diabetic retinopathy with macular edema?

Leonard H. Ginsburg, MD

Video
Published 2019

Related

Widefield Fluorescein Angiographic-Guided Aflibercept (WFFAGA) Monotherapy for Proliferative Diabetic Retinopathy (PDR)
Dennis M. Marcus, MD
Annual Meeting Talks
2019
48-Week End of Study Results From BEHOLD Phase 2 Study of UBX1325 in Patients With DME
Arshad M. Khanani, MD, MA, FASRS
Annual Meeting Talks
2023
Phase 2 Study of Two Formulations of AR-1105 in Macular Edema (ME) Secondary to Retinal Vein Occlusion (RVO)
Michael A. Singer, MD
Annual Meeting Talks
2021

Category: Practice Management - Coding - Computers

See more